Fluxys Belgium NV [FLUX] vs Argenx SE [ARGX] Detailed Stock Comparison

Fluxys Belgium NV

Euronext
Loading...

Argenx SE

Euronext
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fluxys Belgium NV wins in 8 metrics, Argenx SE wins in 10 metrics, with 0 ties. Argenx SE appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricFluxys Belgium NVArgenx SEBetter
P/E Ratio (TTM)17.4438.09Fluxys Belgium NV
Price-to-Book Ratio2.386.40Fluxys Belgium NV
Debt-to-Equity Ratio392.770.71Argenx SE
PEG Ratio17.8978.28Fluxys Belgium NV
EV/EBITDA8.9975.76Fluxys Belgium NV
Profit Margin (TTM)11.97%41.03%Argenx SE
Operating Margin (TTM)20.11%21.08%Argenx SE
EBITDA Margin (TTM)20.11%21.08%Argenx SE
Return on Equity13.48%24.72%Argenx SE
Return on Assets (TTM)2.51%4.83%Argenx SE
Free Cash Flow (TTM)$199.24M$-128.75MFluxys Belgium NV
Dividend Yield6.76%N/AN/A
1-Year Return30.32%28.30%Fluxys Belgium NV
Price-to-Sales Ratio (TTM)2.1112.71Fluxys Belgium NV
Enterprise Value$2.65B$30.29BArgenx SE
EV/Revenue Ratio3.8211.39Fluxys Belgium NV
Gross Profit Margin (TTM)N/A88.32%N/A
Revenue per Share (TTM)$10$51Argenx SE
Earnings per Share (Diluted)$1.17$16.75Argenx SE
Beta (Stock Volatility)0.350.00Argenx SE
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Fluxys Belgium NV vs Argenx SE Stock Performance Analysis

Loading Price Chart...

Fluxys Belgium NV
Argenx SE
Fluxys Belgium NV Stock Overview | Argenx SE Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fluxys Belgium NV2.02%-0.49%-0.49%-2.42%10.08%28.66%
Argenx SE-1.40%-5.56%7.85%30.80%9.45%1.24%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fluxys Belgium NV30.32%-31.99%-28.87%-18.19%-29.62%-29.62%
Argenx SE28.30%73.61%195.04%6,578.19%7,777.71%7,777.71%

News Based Sentiment: Fluxys Belgium NV vs Argenx SE

Fluxys Belgium NV

News based Sentiment: NEUTRAL

September presented operational challenges for Fluxys with the Dunkirk LNG terminal strike, but the company demonstrated resilience and analysts maintained a positive outlook. The upcoming Half Year 2025 earnings release on September 28th will be critical in determining the true impact of these disruptions and shaping the investment narrative.

View Fluxys Belgium NV News Sentiment Analysis

Argenx SE

News based Sentiment: POSITIVE

September was a strong month for Argenx, driven by positive clinical trial data for both VYVGART and ARGX-119, multiple analyst upgrades and increased price targets, and continued institutional investment. While a single downgrade exists, the overall narrative is overwhelmingly positive, suggesting continued growth potential.

View Argenx SE News Sentiment Analysis

Performance & Financial Health Analysis: Fluxys Belgium NV vs Argenx SE

MetricFLUXARGX
Market Information
Market Cap i€1.43B€39.22B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,16588,466
90 Day Avg. Volume i2,58589,639
Last Close€20.20€618.40
52 Week Range€12.55 - €22.70€456.30 - €664.80
% from 52W High-11.01%-6.98%
All-Time High€37.56 (Feb 04, 2013)€664.80 (Sep 10, 2025)
% from All-Time High-46.22%-6.98%
Growth Metrics
Quarterly Revenue Growth-0.04%0.98%
Quarterly Earnings Growth-0.03%7.44%
Financial Health
Profit Margin (TTM) i0.12%0.41%
Operating Margin (TTM) i0.20%0.21%
Return on Equity (TTM) i0.13%0.25%
Debt to Equity (MRQ) i392.770.71
Cash & Liquidity
Book Value per Share (MRQ)€8.58€99.66
Cash per Share (MRQ)€15.99€64.22
Operating Cash Flow (TTM) i€303.10M€344.16M
Levered Free Cash Flow (TTM) i€105.14M€219.71M
Dividends
Last 12-Month Dividend Yield i6.76%N/A
Last 12-Month Dividend i€1.40N/A

Valuation & Enterprise Metrics Analysis: Fluxys Belgium NV vs Argenx SE

MetricFLUXARGX
Price Ratios
P/E Ratio (TTM) i17.4438.09
Forward P/E i17.8978.28
PEG Ratio i17.8978.28
Price to Sales (TTM) i2.1112.71
Price to Book (MRQ) i2.386.40
Market Capitalization
Market Capitalization i€1.43B€39.22B
Enterprise Value i€2.65B€30.29B
Enterprise Value Metrics
Enterprise to Revenue i3.8211.39
Enterprise to EBITDA i8.9975.76
Risk & Other Metrics
Beta i0.350.00
Book Value per Share (MRQ) i€8.58€99.66

Financial Statements Comparison: Fluxys Belgium NV vs Argenx SE

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)FLUXARGX
Revenue/Sales iN/A€801.60M
Cost of Goods Sold iN/A€93.65M
Gross Profit iN/A€707.95M
Research & Development iN/A€277.10M
Operating Income (EBIT) iN/A€172.37M
EBITDA iN/A€202.49M
Pre-Tax Income iN/A€242.60M
Income Tax iN/A€35.13M
Net Income (Profit) iN/A€207.47M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)FLUXARGX
Cash & Equivalents i€1.09B€1.78B
Total Current Assets i€1.30B€4.97B
Total Current Liabilities i€387.90M€888.12M
Long-Term Debt i€1.03B€30.32M
Total Shareholders Equity i€603.81M€5.20B
Retained Earnings i€542.78M€-986.21M
Property, Plant & Equipment i€5.55BN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)FLUXARGX
Operating Cash Flow iN/A€-5.64M
Capital Expenditures iN/A€-44,328
Free Cash Flow iN/A€281,661
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFLUXARGX
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i2,16588,466
Average Daily Volume (90 Day) i2,58589,639
Shares Outstanding i70.26M51.79M
Float Shares i7.03M61.15M
% Held by Insiders i0.90%0.00%
% Held by Institutions i0.00%0.41%

Dividend Analysis & Yield Comparison: Fluxys Belgium NV vs Argenx SE

MetricFLUXARGX
Last 12-Month Dividend i€1.40N/A
Last 12-Month Dividend Yield i6.76%N/A
3-Year Avg Annual Dividend i€1.40N/A
3-Year Avg Dividend Yield i6.25%N/A
3-Year Total Dividends i€4.20N/A
Ex-Dividend DateMay 19, 2025N/A